SunTrust Banks Analysts Give Express Scripts (ESRX) a $82.00 Price Target

SunTrust Banks set a $82.00 target price on Express Scripts (NASDAQ:ESRX) in a research note published on Thursday. The firm currently has a buy rating on the stock.

ESRX has been the subject of a number of other reports. Jefferies Group set a $72.00 price target on Express Scripts and gave the company a buy rating in a research note on Tuesday, August 29th. Mizuho set a $67.00 price objective on Express Scripts and gave the stock a hold rating in a research note on Tuesday, October 24th. ValuEngine upgraded Express Scripts from a hold rating to a buy rating in a report on Monday, December 4th. Royal Bank of Canada began coverage on Express Scripts in a report on Tuesday, September 19th. They issued a sector perform rating and a $68.00 target price for the company. Finally, UBS lowered Express Scripts from a market perform rating to an underperform rating in a report on Monday, October 9th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of Hold and an average price target of $74.40.

Shares of Express Scripts (NASDAQ ESRX) opened at $71.55 on Thursday. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. The firm has a market capitalization of $40,523.99, a P/E ratio of 10.46, a PEG ratio of 1.06 and a beta of 0.88. Express Scripts has a 1 year low of $55.80 and a 1 year high of $73.42.

Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.90. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The business had revenue of $24.68 billion during the quarter, compared to analyst estimates of $25.68 billion. During the same period in the prior year, the company posted $1.74 EPS. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year. research analysts predict that Express Scripts will post 7.02 earnings per share for the current fiscal year.

In other news, VP Phyllis S. Anderson sold 643 shares of Express Scripts stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total value of $40,103.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Timothy C. Wentworth bought 8,000 shares of the business’s stock in a transaction dated Tuesday, October 31st. The stock was purchased at an average price of $61.13 per share, with a total value of $489,040.00. Following the purchase, the chief executive officer now directly owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. 0.68% of the stock is currently owned by insiders.

A number of hedge funds have recently bought and sold shares of the stock. Parametric Portfolio Associates LLC raised its position in Express Scripts by 25.8% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 1,551,526 shares of the company’s stock worth $98,243,000 after purchasing an additional 317,878 shares during the last quarter. Chicago Partners Investment Group LLC grew its holdings in Express Scripts by 374.2% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,766 shares of the company’s stock worth $302,000 after acquiring an additional 3,761 shares during the period. Steward Partners Investment Advisory LLC acquired a new stake in Express Scripts during the 3rd quarter worth $467,000. Optimum Investment Advisors grew its holdings in Express Scripts by 64.7% during the 3rd quarter. Optimum Investment Advisors now owns 5,471 shares of the company’s stock worth $346,000 after acquiring an additional 2,150 shares during the period. Finally, Wealthsource Partners LLC acquired a new stake in Express Scripts during the 3rd quarter worth $224,000. Hedge funds and other institutional investors own 88.44% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://sportsperspectives.com/2017/12/18/suntrust-banks-analysts-give-express-scripts-esrx-a-82-00-price-target.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply